샘플 요청 목록

 카트 문의
시장보고서
상품코드
1775022

원숭이두창 백신 및 치료 시장

Monkeypox Vaccine and Treatment
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 455 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

원숭이두창 백신 및 치료 세계 시장은 2030년까지 1억 6,050만 달러에 달할 전망

2024년에 1억 40만 달러로 추정되는 원숭이두창 백신 및 치료 세계 시장은 2030년에는 1억 6,050만 달러에 달하고, 분석 기간인 2024-2030년 CAGR은 8.1%로 성장할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 원숭이두창 백신은 CAGR 7.2%를 기록하며 분석 기간 종료시에는 1억 720만 달러에 달할 것으로 예측됩니다. 원숭이두창 치료제 부문의 성장률은 분석 기간 동안 CAGR 10.1%로 추정됩니다.

미국 시장은 2,740만 달러로 추정, 중국은 CAGR 12.5%로 성장할 것으로 예측

미국의 원숭이두창 백신 및 치료 시장은 2024년에 2,740만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석 기간 2024년부터 2030년까지 CAGR 12.5%를 더듬어, 2030년에는 예측 시장 규모 3,420만 달러에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 4.2%와 7.7%로 예측됩니다. 유럽에서는 독일이 CAGR 5.4%로 성장할 것으로 예측됩니다.

세계 원숭이두창 백신 및 치료 시장 - 주요 동향 및 촉진요인 정리

전 세계적으로 원숭이두창 백신 및 치료에 대한 수요가 증가한 이유는 무엇일까?

전 세계적으로 원숭이두창가 재유행하면서 효과적인 백신 및 치료에 대한 수요가 크게 증가하고 있습니다. 과거에는 중앙아프리카와 서아프리카에 국한된 희귀한 인수공통전염병으로 여겨졌던 원숭이두가 현재는 많은 국가로 확산되고 있으며, 세계보건기구(WHO)와 공중보건기구는 원숭이두를 세계보건위협으로 분류하고 있습니다. 도시 지역에서는 사람 간 감염도 나타나고 있어 예방접종 캠페인과 항바이러스 치료가 시급한 실정입니다. 정부와 보건 기관은 특히 면역력이 약한 사람, 의료 종사자, 감염자에 노출된 사람 등 고위험군에 대한 백신 조달 및 배포를 위한 자금을 증액하고 있습니다. 또한, 향후 발생할 수 있는 발병에 대한 장기적인 면역의 필요성 때문에 효능이 향상되고 예방 효과가 더 오래 지속되는 차세대 백신에 대한 연구도 가속화되고 있습니다.

어떤 과학적 발전이 원숭이두창 백신 및 치료법 개발을 형성하고 있는가?

원숭이두창 백신 및 치료제 개발은 바이러스학, 면역학, 생명공학의 발전에 큰 영향을 받고 있습니다. 가장 널리 사용되는 백신은 개량형 백신인 MVA(Modified Vaccine Vaccine Ankara)베이스의 백신으로, 원래 천연두용으로 개발되었으나 원숭이두창에 대한 교차방어 면역을 위해 재사용되고 있습니다. 안전성 프로파일을 개선하고 확장성을 높인 차세대 백신은 부작용이 적고 장기적인 면역을 제공하는 것을 목표로 개발 중입니다. 이와 병행하여 테코비리무트(TPOXX), 브린시도포비르, 시드포비르 등의 항바이러스 치료는 증상의 심각성을 줄이고 합병증을 예방하는 효과적인 대안으로 확인되고 있습니다. 단클론항체를 치료 요법에 포함시켜 중증 환자에서 면역반응을 높이는 방안도 검토되고 있습니다. 또한, COVID-19 백신 접종에 혁명을 가져온 mRNA 백신 기술은 새로운 바이러스 변이에 빠르게 적응할 수 있는 표적형 원숭이두창 백신 개발에도 적용될 수 있을 것으로 연구되고 있습니다. 연구개발에 대한 투자가 증가함에 따라 원숭이두창 백신 및 치료법의 미래는 유망하며, 예방과 치료 성적이 향상될 것으로 기대됩니다.

정부 정책과 공중보건 전략은 시장 성장에 어떤 영향을 미치고 있는가?

세계 각국 정부는 원숭이두창의 확산을 막기 위해 적극적인 백신 접종 전략과 치료 접근성 프로그램을 시행하고 있으며, 이는 백신 및 치료 시장 수요를 견인하고 있습니다. 미국 식품의약국(FDA), 유럽의약품청(EMA) 등 규제기관의 긴급사용승인(EUA) 및 신속 승인으로 백신과 항바이러스제의 접근이 가속화되고 있습니다. 국가 예방접종 프로그램에서는 위험에 처한 사람들에게 우선적으로 백신을 배포하고, 비축된 천연두 백신의 배치를 진행했습니다. 대중 계몽 캠페인과 지역 보건 활동도 백신 접종과 조기 치료의 보급에 기여하고 있습니다. 또한, WHO와 CEPI(Coalition for Epidemic Preparedness Innovations)와 같은 국제 보건기구의 자금 지원 이니셔티브는 대규모 임상시험과 백신 생산능력 확대를 지원했습니다. 각국 정부들이 전염병에 대한 대비를 최우선 과제로 삼고 있는 가운데, 연구에 대한 투자도 증가할 것으로 예상됩니다.

원숭이두창 백신 및 치료 시장의 성장을 촉진하는 주요 요인은 무엇인가?

원숭이두창 백신 및 치료 시장의 성장은 환자 수 증가, 백신 개발의 진전, 정부의 강력한 개입 등 여러 요인에 의해 주도되고 있습니다. 팬데믹 대비와 바이오 보안 대책에 대한 관심이 높아지면서 백신 연구에 대한 투자 확대와 항바이러스제 비축이 전 세계적으로 확대되고 있습니다. 생산 시설의 확장 및 백신 유통 경로의 개선도 시장 성장을 촉진하고 있습니다. 또한, mRNA 기반 제제를 포함한 새로운 백신 기술로의 전환은 시장 확대의 새로운 기회를 창출하고 있습니다. 집단 예방접종 프로그램과 적극적인 검사 전략의 채택이 확대되면서 원숭이두창 관련 의료 개입에 대한 수요가 더욱 증가하고 있습니다. 또한, 제약회사와 정부 간의 비공개 파트너십을 통해 백신의 신속한 보급과 치료에 대한 공평한 접근을 보장하고 있습니다. 원숭이두창는 여전히 공중 보건에 위협이 되고 있기 때문에 현재 진행 중인 연구와 세계 백신 접종 이니셔티브에 힘입어 백신 및 치료 시장은 지속적인 성장이 예상됩니다.

부문

제품 유형(원숭이두창 백신, 원숭이두창 치료제), 성별(남성, 여성, 기타), 투여 경로(경구 투여, 주사 투여), 최종사용자(병원 최종사용자, 전문 클리닉 최종사용자, 기타 최종사용자)

조사 대상 기업 사례

  • Abbott Laboratories
  • AstraZeneca plc
  • Bavarian Nordic A/S
  • BioFactura, Inc.
  • BioNTech SE
  • Chimerix, Inc.
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • KM Biologics Co., Ltd.
  • Merck & Co., Inc.
  • Moderna, Inc.
  • Novavax, Inc.
  • Pfizer Inc.
  • Roche Holding AG
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd.
  • SIGA Technologies, Inc.
  • Tonix Pharmaceuticals Holding Corp.

AI 통합

우리는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.08.01

Global Monkeypox Vaccine and Treatment Market to Reach US$160.5 Million by 2030

The global market for Monkeypox Vaccine and Treatment estimated at US$100.4 Million in the year 2024, is expected to reach US$160.5 Million by 2030, growing at a CAGR of 8.1% over the analysis period 2024-2030. Monkeypox Vaccines, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$107.2 Million by the end of the analysis period. Growth in the Monkeypox Drugs segment is estimated at 10.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$27.4 Million While China is Forecast to Grow at 12.5% CAGR

The Monkeypox Vaccine and Treatment market in the U.S. is estimated at US$27.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$34.2 Million by the year 2030 trailing a CAGR of 12.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 7.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.

Global Monkeypox Vaccine and Treatment Market - Key Trends & Drivers Summarized

Why Has the Demand for Monkeypox Vaccines and Treatments Increased Worldwide?

The resurgence of monkeypox in multiple regions across the globe has led to a significant rise in demand for effective vaccines and treatments. Previously considered a rare zoonotic disease confined to Central and West Africa, monkeypox has now spread to numerous countries, prompting the World Health Organization (WHO) and public health agencies to classify it as a growing global health threat. The emergence of human-to-human transmission in urban settings has intensified the urgency for immunization campaigns and antiviral treatments to curb outbreaks. Governments and health organizations have increased funding for vaccine procurement and distribution, particularly for high-risk populations such as immunocompromised individuals, healthcare workers, and those exposed to infected individuals. The need for long-term immunity against potential future outbreaks has also accelerated research into next-generation vaccines with improved efficacy and longer-lasting protection.

What Scientific Advancements Are Shaping the Development of Monkeypox Vaccines and Treatments?

The development of vaccines and therapeutics for monkeypox has been significantly influenced by advances in virology, immunology, and biotechnology. The most widely used vaccines are modified vaccinia virus Ankara (MVA)-based vaccines, originally developed for smallpox but repurposed due to their cross-protective immunity against monkeypox. Next-generation vaccines with improved safety profiles and higher scalability are under development, aiming to provide long-term immunity with fewer side effects. In parallel, antiviral treatments such as tecovirimat (TPOXX), brincidofovir, and cidofovir have been identified as effective options for reducing symptom severity and preventing complications. The integration of monoclonal antibodies into treatment regimens is also being explored to enhance immune response in severe cases. Additionally, mRNA vaccine technology, which revolutionized COVID-19 vaccination, is being studied for its potential application in developing targeted monkeypox vaccines with rapid adaptability to emerging viral mutations. With increasing investment in research and development, the future of monkeypox vaccines and treatments looks promising, offering improved protection and treatment outcomes.

How Are Government Policies and Public Health Strategies Influencing Market Growth?

Governments worldwide have implemented aggressive vaccination strategies and treatment access programs to control the spread of monkeypox, driving market demand for vaccines and therapeutics. Emergency use authorizations (EUAs) and fast-track approvals by regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accelerated the availability of vaccines and antiviral drugs. National immunization programs have prioritized at-risk populations, leading to increased vaccine distribution and deployment of stockpiled smallpox vaccines. Public awareness campaigns and community health initiatives have further contributed to vaccination uptake and early treatment adoption. Additionally, funding initiatives by global health organizations, including the WHO and the Coalition for Epidemic Preparedness Innovations (CEPI), have supported large-scale clinical trials and expanded vaccine manufacturing capabilities. As governments continue to prioritize pandemic preparedness, investment in monkeypox vaccine and treatment research is expected to rise.

What Are the Key Factors Driving the Growth of the Monkeypox Vaccine and Treatment Market?

The growth in the monkeypox vaccine and treatment market is driven by several factors, including the rising number of cases, advancements in vaccine development, and strong government intervention. The increased focus on pandemic preparedness and biosecurity measures has led to higher investments in vaccine research and global stockpiling of antiviral drugs. The expansion of production facilities and improvements in vaccine distribution channels are also fueling market growth. Additionally, the shift toward novel vaccine technologies, including mRNA-based formulations, is creating new opportunities for market expansion. The growing adoption of mass immunization programs and proactive testing strategies is further driving demand for monkeypox-related medical interventions. Furthermore, public-private partnerships between pharmaceutical companies and governments are ensuring rapid vaccine rollout and equitable access to treatments. As monkeypox continues to pose a public health threat, the market for vaccines and treatments is expected to witness sustained growth, driven by ongoing research and global vaccination initiatives.

SCOPE OF STUDY:

The report analyzes the Monkeypox Vaccine and Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Monkeypox Vaccines, Monkeypox Drugs); Gender (Male Gender, Female Gender, Other Genders); Administration Route (Oral Administration, Injectable Administration); End-Use (Hospitals End-Use, Specialty Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • Abbott Laboratories
  • AstraZeneca plc
  • Bavarian Nordic A/S
  • BioFactura, Inc.
  • BioNTech SE
  • Chimerix, Inc.
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • KM Biologics Co., Ltd.
  • Merck & Co., Inc.
  • Moderna, Inc.
  • Novavax, Inc.
  • Pfizer Inc.
  • Roche Holding AG
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd.
  • SIGA Technologies, Inc.
  • Tonix Pharmaceuticals Holding Corp.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Monkeypox Vaccine and Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surge in Monkeypox Outbreaks Accelerates Global Demand for Vaccines and Therapeutics
    • Rising Global Awareness of Monkeypox as a Threat to Public Health Drives Vaccine and Treatment Adoption
    • Increasing Government and Global Health Organization Investments Strengthen Market Opportunities for Monkeypox Vaccines
    • Expansion of Vaccine Distribution Networks Enhances Global Access and Adoption of Monkeypox Vaccines
    • Advancements in Vaccine Technology Improve Efficacy and Speed of Development for Monkeypox Vaccines
    • Strong Focus on Emergency Preparedness and Pandemic Response Systems Expands Market for Monkeypox Vaccines and Treatments
    • Increasing Number of Monkeypox Cases in Non-endemic Regions Boosts Demand for Preventive and Therapeutic Solutions
    • Rising Public Health Funding and Global Collaboration on Infectious Disease Prevention Strengthens Business Case for Monkeypox Vaccines
    • Growing Demand for Monoclonal Antibodies and Antiviral Treatments for Monkeypox Drives Innovation in Therapeutics
    • Technological Advancements in Vaccine Manufacturing Processes Enable Faster Production and Scalability for Monkeypox Vaccines
    • Regulatory Approvals and Emergency Use Authorizations Accelerate Market Entry and Adoption of Monkeypox Vaccines and Treatments
    • Increasing Incidents of Monkeypox in High-Risk Populations Creates Urgency for Targeted Vaccination Programs
    • Heightened Focus on Vaccine Equity and Access in Low- and Middle-income Countries Expands Market Reach for Monkeypox Vaccines
    • Adoption of Preventive Vaccination Strategies in Endemic and Non-endemic Regions Accelerates Growth in Vaccine Demand
    • Rising Concern Over Cross-border Transmission of Monkeypox in International Travel Propels Demand for Vaccines
    • Integration of Monkeypox Vaccines into Routine Immunization Programs Strengthens Long-term Growth Outlook
    • Emergence of New Treatment Modalities and Drug Therapies for Monkeypox Expands Market Options for Healthcare Providers
    • Advancements in Vaccine Delivery Platforms, Including Intradermal and Nasal Vaccines, Enhance Market Appeal
    • Public-private Partnerships to Address Infectious Disease Control Accelerate Development and Distribution of Monkeypox Vaccines and Treatments
    • Ongoing Research into Broader Spectrum Vaccines for Orthopoxviruses Increases Market Potential for Monkeypox Immunization
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Monkeypox Vaccine and Treatment Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Monkeypox Vaccine and Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Monkeypox Vaccine and Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Monkeypox Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Monkeypox Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Monkeypox Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Monkeypox Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Monkeypox Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Monkeypox Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Male Gender by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Male Gender by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Male Gender by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Female Gender by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Female Gender by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Female Gender by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Genders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Genders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other Genders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Oral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Injectable Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Injectable Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Injectable Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Monkeypox Vaccine and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • JAPAN
    • Monkeypox Vaccine and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • CHINA
    • Monkeypox Vaccine and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 71: China Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • EUROPE
    • Monkeypox Vaccine and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Monkeypox Vaccine and Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Monkeypox Vaccine and Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • FRANCE
    • Monkeypox Vaccine and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 98: France Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 107: France Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • GERMANY
    • Monkeypox Vaccine and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: Germany 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: Germany 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 116: Germany Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: Germany 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 122: Italy Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Italy 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 125: Italy Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Italy Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Italy 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Italy 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Monkeypox Vaccine and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 134: UK Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: UK Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: UK 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 137: UK Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: UK Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: UK 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 140: UK Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: UK 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 143: UK Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 146: Spain Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Spain Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: Spain 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 149: Spain Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Spain Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: Spain 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 152: Spain Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Spain Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: Spain 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 155: Spain Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Spain Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Spain 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 158: Russia Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Russia Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Russia 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 161: Russia Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Russia Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Russia 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 164: Russia Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Russia Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: Russia 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 167: Russia Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Russia Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: Russia 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Europe Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Europe 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Europe Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: Rest of Europe 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Europe Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Europe 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Europe Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Europe 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Monkeypox Vaccine and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 183: Asia-Pacific Historic Review for Monkeypox Vaccine and Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: Asia-Pacific 15-Year Perspective for Monkeypox Vaccine and Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Asia-Pacific Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: Asia-Pacific 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Asia-Pacific Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: Asia-Pacific 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 193: Asia-Pacific 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 196: Asia-Pacific 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Monkeypox Vaccine and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 197: Australia Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Australia Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 199: Australia 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 200: Australia Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Australia Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 202: Australia 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 203: Australia Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Australia Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 205: Australia 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 206: Australia Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Australia Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 208: Australia 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • INDIA
    • Monkeypox Vaccine and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 209: India Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 210: India Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 211: India 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 212: India Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 213: India Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 214: India 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 215: India Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 216: India Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 217: India 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 218: India Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 219: India Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 220: India 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 221: South Korea Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 222: South Korea Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 223: South Korea 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 224: South Korea Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 225: South Korea Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 226: South Korea 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 227: South Korea Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 228: South Korea Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 229: South Korea 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 230: South Korea Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 231: South Korea Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 232: South Korea 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 233: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Asia-Pacific Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Asia-Pacific 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Asia-Pacific Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Asia-Pacific Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Asia-Pacific Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Monkeypox Vaccine and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 245: Latin America Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 246: Latin America Historic Review for Monkeypox Vaccine and Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 247: Latin America 15-Year Perspective for Monkeypox Vaccine and Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 248: Latin America Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Latin America Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 250: Latin America 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 251: Latin America Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Latin America Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 253: Latin America 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 256: Latin America 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 257: Latin America Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Latin America Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 259: Latin America 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 260: Argentina Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Argentina Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 262: Argentina 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 263: Argentina Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Argentina Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 265: Argentina 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 266: Argentina Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Argentina Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 268: Argentina 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 269: Argentina Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Argentina Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 271: Argentina 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 272: Brazil Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Brazil Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 274: Brazil 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 275: Brazil Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Brazil Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 277: Brazil 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 278: Brazil Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Brazil Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 280: Brazil 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 281: Brazil Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Brazil Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 283: Brazil 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 284: Mexico Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Mexico Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 286: Mexico 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 287: Mexico Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Mexico Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 289: Mexico 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 290: Mexico Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Mexico Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 292: Mexico 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 293: Mexico Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Mexico Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 295: Mexico 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 296: Rest of Latin America Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Latin America Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Latin America 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Latin America Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Latin America 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Latin America Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Latin America 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Latin America Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Latin America 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Monkeypox Vaccine and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 308: Middle East Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 309: Middle East Historic Review for Monkeypox Vaccine and Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 310: Middle East 15-Year Perspective for Monkeypox Vaccine and Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 311: Middle East Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Middle East Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 313: Middle East 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 314: Middle East Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Middle East Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 316: Middle East 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 319: Middle East 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 320: Middle East Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Middle East Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 322: Middle East 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 323: Iran Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Iran Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 325: Iran 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 326: Iran Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Iran Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 328: Iran 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 329: Iran Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Iran Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 331: Iran 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 332: Iran Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Iran Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 334: Iran 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 335: Israel Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Israel Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 337: Israel 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 338: Israel Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Israel Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 340: Israel 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 341: Israel Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Israel Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 343: Israel 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 344: Israel Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Israel Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 346: Israel 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 347: Saudi Arabia Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Saudi Arabia Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 349: Saudi Arabia 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Saudi Arabia Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 352: Saudi Arabia 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Saudi Arabia Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 355: Saudi Arabia 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Saudi Arabia Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 358: Saudi Arabia 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 359: UAE Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 360: UAE Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 361: UAE 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 362: UAE Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 363: UAE Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 364: UAE 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 365: UAE Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 366: UAE Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 367: UAE 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 368: UAE Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 369: UAE Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 370: UAE 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 371: Rest of Middle East Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Rest of Middle East Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 373: Rest of Middle East 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Rest of Middle East Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 376: Rest of Middle East 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Rest of Middle East Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 379: Rest of Middle East 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Rest of Middle East Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 382: Rest of Middle East 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • AFRICA
    • Monkeypox Vaccine and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 383: Africa Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Africa Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 385: Africa 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 386: Africa Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Africa Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 388: Africa 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 389: Africa Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Africa Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 391: Africa 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 392: Africa Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Africa Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 394: Africa 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제